Abstract:CD8+ T lymphocytes are components of the adaptive immune response and play an important role in protection against many viral and bacterial infections. However, their role in parasitic infections is less well understood. In leishmaniasis, a disease caused by intracellular protozoan parasites of the genus Leishmania, CD8+ T cells have been shown to be protective. However, increasing evidence indicates that CD8+ T cells may also exacerbate disease. In this review, we will describe the situations where CD8+ T cel… Show more
“…CD8 T cells are protective in leishmaniasis, both during a primary and secondary infection, and can also mediate protection in leishmanial vaccines (21). Paradoxically, however, it is now clear that CD8 T cells also induce increased pathology in cutaneous leishmaniasis (21–25).…”
Section: Resultsmentioning
confidence: 99%
“…Paradoxically, however, it is now clear that CD8 T cells also induce increased pathology in cutaneous leishmaniasis (21–25). We previously identified two types of pathologic CD8 T cells in mice, a population that are Leishmania- specific and another population of bystander memory CD8 T cells (7, 22).…”
Section: Resultsmentioning
confidence: 99%
“…CD8 T cells play a protective role in leishmaniasis, due to their production of IFN-γ that can both activate macrophages to kill the parasites and enhance the CD4+ Th1 response (21). However, there is increasing evidence that CD8 T cells also act to promote tissue damage in cutaneous leishmaniasis (22, 32).…”
Leishmaniasis is a significant neglected tropical disease that is associated with a wide range of clinical presentations and a life long persistent infection. Due to the chronic nature of the disease there is a high risk of co-infection occurring in patients, and how co-infections influence the outcome of leishmaniasis is poorly understood. To address this issue, we infected mice with Leishmania major and two weeks later with lymphocytic choriomeningitis virus (LCMV), and monitored the course of infection. Leishmania parasites are controlled by production of IFN-γ, which leads to macrophage mediated parasite killing. Thus, one might predict that co-infection with LCMV, which induces a strong systemic type 1 response, would accelerate disease resolution. However, we found that infection with LCMV led to significantly enhanced disease in L. major infected animals. This increased disease correlated with an infiltration into the leishmanial lesions of NKG2D+ CD8+ T cells producing granzyme B, but surprisingly little IFN-γ. We found that depletion of CD8 T cells after viral clearance, as well as blockade of NKG2D, reversed the increased pathology seen in co-infected mice. Thus, this work highlights the impact a secondary infection can have on leishmaniasis, and demonstrates that even pathogens known to promote a type 1 response may exacerbate leishmanial infections.
“…CD8 T cells are protective in leishmaniasis, both during a primary and secondary infection, and can also mediate protection in leishmanial vaccines (21). Paradoxically, however, it is now clear that CD8 T cells also induce increased pathology in cutaneous leishmaniasis (21–25).…”
Section: Resultsmentioning
confidence: 99%
“…Paradoxically, however, it is now clear that CD8 T cells also induce increased pathology in cutaneous leishmaniasis (21–25). We previously identified two types of pathologic CD8 T cells in mice, a population that are Leishmania- specific and another population of bystander memory CD8 T cells (7, 22).…”
Section: Resultsmentioning
confidence: 99%
“…CD8 T cells play a protective role in leishmaniasis, due to their production of IFN-γ that can both activate macrophages to kill the parasites and enhance the CD4+ Th1 response (21). However, there is increasing evidence that CD8 T cells also act to promote tissue damage in cutaneous leishmaniasis (22, 32).…”
Leishmaniasis is a significant neglected tropical disease that is associated with a wide range of clinical presentations and a life long persistent infection. Due to the chronic nature of the disease there is a high risk of co-infection occurring in patients, and how co-infections influence the outcome of leishmaniasis is poorly understood. To address this issue, we infected mice with Leishmania major and two weeks later with lymphocytic choriomeningitis virus (LCMV), and monitored the course of infection. Leishmania parasites are controlled by production of IFN-γ, which leads to macrophage mediated parasite killing. Thus, one might predict that co-infection with LCMV, which induces a strong systemic type 1 response, would accelerate disease resolution. However, we found that infection with LCMV led to significantly enhanced disease in L. major infected animals. This increased disease correlated with an infiltration into the leishmanial lesions of NKG2D+ CD8+ T cells producing granzyme B, but surprisingly little IFN-γ. We found that depletion of CD8 T cells after viral clearance, as well as blockade of NKG2D, reversed the increased pathology seen in co-infected mice. Thus, this work highlights the impact a secondary infection can have on leishmaniasis, and demonstrates that even pathogens known to promote a type 1 response may exacerbate leishmanial infections.
“…+ T-cells' contribution is undoubtedly necessary for VL control but remains controversial regarding CL control [15,16]. Our previous study clearly evaluated CD8 + T-cells stimulation by a polytope construct containing H-2Kd restricted epitopes from non-vaccine protein candidates of Leishmania major [17].…”
“…The recent identification of a protein, phosphoenolpyruvate carboxykinase, that reacts with approximately 20% of L. major -specific CD4 T cells and has broad cross-reactivity may help resolve this need, and will also be an invaluable tool for assessing CD4 responses [29]. CD8 T cells have been shown to be protective in some vaccine and mouse models [64], but also might be problematic as CD8 cytotoxic lymphocytes are associated with increased pathology in Leishmania braziliensis [23,65]. …”
Section: Implications For the Development Of A Cutaneous Leishmanimentioning
Leishmania causes a spectrum of diseases that range from self-healing to fatal infections. Control of leishmania is dependent upon generating CD4+ Th1 cells that produce IFNγ, leading to macrophage activation and killing of the intracellular parasites. Following resolution of the disease, short-lived effector T cells, as well as long-lived central memory T cells and skin resident memory T cells, are retained and able to mediate immunity to a secondary infection. However, there is no vaccine for leishmaniasis, and the drugs used to treat the disease can be toxic and ineffective. While a live infection generates immunity, a successful vaccine will depend upon generating memory T cells that can be maintained without the continued presence of parasites. Since both central memory and skin resident memory T cells are long-lived, they may be the appropriate targets for a leishmaniasis vaccine.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.